Literature DB >> 14839200

Triaethyleneimino-s-triazine in human malignant disease: a preliminary trial.

E PATERSON, J BOLAND.   

Abstract

Entities:  

Keywords:  TRIAZINE

Mesh：

Substances：

Year:  1951        PMID： 14839200      PMCID： PMC2007760          DOI： 10.1038/bjc.1951.3

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  2 in total

1.  Chemotherapy of leukemia. V. Effects of 2,4,6-triethylenimino-S-triazine and related compounds on transplanted mouse leukemia.

Authors:  J H BURCHENAL; S F JOHNSTON; M A CREMER; L F WEBBER; C C STOCK
Journal:  Proc Soc Exp Biol Med       Date:  1950-08

2.  New cytotoxic agents with tumour-inhibitory activity.

Authors:  F L ROSE; J A HENDRY; A L WALPOLE
Journal:  Nature       Date:  1950-06-24       Impact factor: 49.962
  2 in total
  5 in total

1.  Chemical agents in neoplastic diseases; an evaluation of chemotherapeutic substances for clinical management.

Authors:  H R BIERMAN
Journal:  Calif Med       Date:  1953-01

2.  [Fatal uremia after triethylenemelamine treatment in chronic lymphatic leukemia].

Authors:  H MARTIN
Journal:  Klin Wochenschr       Date:  1953-03-15

3.  BACTERIA at the sea bottom.

Authors: 
Journal:  Br Med J       Date:  1952-06-21

4.  The development of tamoxifen for breast cancer therapy: a tribute to the late Arthur L. Walpole.

Authors:  V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1988-07       Impact factor: 4.872

5.  Discussion on the chemotherapy of the reticuloses.

Authors:  J F WILKINSON; A HADDOW; J D NABARRO
Journal:  Proc R Soc Med       Date:  1953-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.